Please assess the completion status of the following clinical trial:

Trial Title: Broccoli Sprout Extract Effects on Allergic Inflammation in the Nose

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Able and willing to provide informed consent~* DEP responder as defined in protocol~* Ability to refrain from consuming cruciferous vegetables 3 days prior to starting study and while on study. Cruciferous vegetables include: Broccoli, Kale, Chard, Kohlrabi, Brussels Sprouts, Parsley, Watercress, Daikon, Cabbage, Rutabagas, Cauliflower, Bok Choy, Arugula, Turnips, Radish, Mustard and Collard greens.~* Allergy skin test positive to cat~* Nonsmoker or ex-smoker of more than one year~Exclusion Criteria:~* Smoking within past year or during study~* Systemic corticosteroid or other immunosuppressive medication use in the previous 3 months or during study~* Intranasal corticosteroid use in the previous month or during the study~* Intranasal antihistamine or cromolyn use in the previous week or during study~* Allergen immunotherapy during the previous 12 months or during study~* Omalizumab use in the previous 12 months or during study~* Systemic antihistamine or leukotriene modifying medication use in the previous week or during study~* History of asthma or any current medical condition that in the opinion of the investigator may compromise the subject's ability to safely participate in the study~* Baseline abnormality of hemoglobin, platelets, leukocytes, serum chemistries, liver function testing, or presence of proteinuria~* A finding during physical examination that, in the opinion of the investigator may compromise the participant's ability to safely participate in the study~* Pregnant or breast-feeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- DEP challenge in subjects consuming BSE (Type: EXPERIMENTAL): DEP will be administered in nostrils of participants who received BSE intervention by drinking 1 cup of liquid containing 1.25 g BSE daily for 4 days, or without consuming BSE.

Based on this trial design, predict the completion outcome and termination type (if applicable).